Carroll Financial Associates’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-543
| Closed | -$5K | – | 1713 |
|
|
2019
Q2 | $5K | Buy |
543
+3
| +0.6% | +$28 | ﹤0.01% | 1217 |
|
|
2019
Q1 | $8K | Hold |
540
| – | – | ﹤0.01% | 1007 |
|
|
2018
Q4 | $9K | Hold |
540
| – | – | ﹤0.01% | 896 |
|
|
2018
Q3 | $11K | Hold |
540
| – | – | ﹤0.01% | 875 |
|
|
2018
Q2 | $13K | Hold |
540
| – | – | ﹤0.01% | 804 |
|
|
2018
Q1 | $9K | Hold |
540
| – | – | ﹤0.01% | 866 |
|
|
2017
Q4 | $10K | Sell |
540
-1,000
| -65% | -$18.5K | ﹤0.01% | 832 |
|
|
2017
Q3 | $24K | Sell |
1,540
-243
| -14% | -$3.79K | ﹤0.01% | 616 |
|
|
2017
Q2 | $59K | Buy |
1,783
+1
| +0.1% | +$33 | 0.01% | 462 |
|
|
2017
Q1 | $57K | Sell |
1,782
-744
| -29% | -$23.8K | 0.01% | 452 |
|
|
2016
Q4 | $91K | Sell |
2,526
-719
| -22% | -$25.9K | 0.01% | 362 |
|
|
2016
Q3 | $149K | Sell |
3,245
-4
| -0.1% | -$184 | 0.02% | 282 |
|
|
2016
Q2 | $163K | Buy |
3,249
+100
| +3% | +$5.02K | 0.03% | 256 |
|
|
2016
Q1 | $168K | Buy |
3,149
+24
| +0.8% | +$1.28K | 0.03% | 241 |
|
|
2015
Q4 | $205K | Hold |
3,125
| – | – | 0.04% | 207 |
|
|
2015
Q3 | $181K | Sell |
3,125
-128
| -4% | -$7.41K | 0.04% | 211 |
|
|
2015
Q2 | $192K | Buy |
3,253
+964
| +42% | +$56.9K | 0.04% | 197 |
|
|
2015
Q1 | $143K | Hold |
2,289
| – | – | 0.06% | 163 |
|
|
2014
Q4 | $129K | Sell |
2,289
-1,104
| -33% | -$62.2K | 0.08% | 143 |
|
|
2014
Q3 | $197K | Sell |
3,393
-57
| -2% | -$3.31K | 0.06% | 152 |
|
|
2014
Q2 | $181K | Buy |
3,450
+118
| +4% | +$6.19K | 0.05% | 166 |
|
|
2014
Q1 | $176K | Hold |
3,332
| – | – | 0.06% | 154 |
|
|
2013
Q4 | $133K | Sell |
3,332
-300
| -8% | -$12K | 0.05% | 178 |
|
|
2013
Q3 | $137K | Buy |
+3,632
| New | +$137K | 0.05% | 173 |
|